Changes in LVEDV, LVEF, and NYHA Functional Class in Patients with CHF
Patient no. | LVEDV (mL) | LVEF (%) | NYHA functional class | ||||||
---|---|---|---|---|---|---|---|---|---|
Baseline | 6 mo | Baseline | 6 mo | Baseline | 6 mo | ||||
Group A | |||||||||
1 | 188 | 178 | 22 | 25 | 4 | 3 | |||
2 | 166 | 146 | 40 | 44 | 3 | 2 | |||
3 | 168 | 160 | 39 | 46 | 3 | 2 | |||
4 | 194 | 144 | 36 | 50 | 3 | 1 | |||
5 | 204 | 236 | 22 | 22 | 3 | 1 | |||
6 | 160 | 96 | 40 | 58 | 3 | 1 | |||
7 | 198 | 176 | 37 | 49 | 3 | 2 | |||
8 | 212 | 191 | 27 | 29 | 3 | 2 | |||
9 | 234 | 215 | 30 | 35 | 3 | 1 | |||
10 | 296 | 299 | 33 | 29 | 4 | 2 | |||
11 | 167 | 98 | 32 | 49 | 4 | 2 | |||
12 | 164 | 148 | 26 | 28 | 3 | 1 | |||
13 | 224 | 197 | 17 | 27 | 3 | 2 | |||
14 | 186 | 134 | 40 | 61 | 4 | 2 | |||
15 | 166 | 158 | 32 | 57 | 3 | 1 | |||
16 | 160 | 132 | 37 | 45 | 4 | 2 | |||
Mean ± SD | 193 ± 36 | 169 ± 51* | 32 ± 7 | 41 ± 13† | 3.3 ± 0.5 | 1.7 ± 0.6‡§ | |||
Group B | |||||||||
1 | 202 | 189 | 36 | 43 | 3 | 2 | |||
2 | 186 | 168 | 38 | 40 | 4 | 3 | |||
3 | 174 | 159 | 32 | 30 | 3 | 2 | |||
4 | 243 | 273 | 37 | 40 | 3 | 3 | |||
5 | 274 | 262 | 32 | 27 | 3 | 2 | |||
6 | 166 | 168 | 30 | 24 | 3 | 3 | |||
7 | 160 | 142 | 34 | 42 | 4 | 3 | |||
8 | 186 | 162 | 33 | 26 | 3 | 2 | |||
9 | 186 | 202 | 36 | 28 | 3 | 1 | |||
10 | 184 | 186 | 30 | 35 | 3 | 3 | |||
11 | 188 | 224 | 28 | 26 | 4 | 3 | |||
12 | 250 | 215 | 40 | 48 | 3 | 3 | |||
13 | 234 | 225 | 38 | 36 | 3 | 2 | |||
14 | 166 | 175 | 40 | 36 | 4 | 2 | |||
15 | 164 | 134 | 24 | 32 | 3 | 2 | |||
16 | 182 | 186 | 38 | 37 | 4 | 2 | |||
Mean ± SD | 197 ± 35 | 192 ± 40 | 34 ± 5 | 34 ± 7 | 3.3 ± 0.5 | 2.4 ± 0.6* |